The rate of growth in retail current value sales of dermatologicals will slow slightly but remain robust in 2025. Demand is supported by a rising population, urbanisation and changing consumer lifestyles. An ageing population and relatively high, though gradually declining, birth rates also supported demand growth. Meanwhile, knowledge and understanding of dermatological products and their effectiveness are improving, largely due to the active efforts of healthcare professionals, including docto

2025 sees dermatologicals in the Philippines benefiting from unusually high temperatures, which have significantly impacted consumer purchasing patterns. The Department of Health issued warnings about increased cases of lice infestations during the summer, linking the outbreaks to extreme weather conditions. This triggered heightened demand for antiparasitics/lice (head and body) treatments, particularly among families and school-aged children. Consumers have become more proactive in addressing

Value sales of dermatologicals are rising in New Zealand in 2025. Hair loss treatments is the fastest-growing subcategory, building on strong momentum from earlier in the review period. While male-pattern baldness remains the most common form, awareness is growing around the impact of hair loss on women, prompting broader interest in treatment options across sexes.

Dermatologicals is expected to register moderate current value growth in Tunisia in 2025. Increasing awareness of dermatological, as well as increasing self-medication, support value sales for products such as haemorrhoid treatments and topical and vaginal antifungals. In 2025, antiparasitics/lice (head and body) treatments is expected to register the highest current value growth. Many parents reported a resurgence of head lice infestations among their children, which led to a spike in demand fo

Value sales of dermatologicals in Nigeria continue to rise in 2025, following the sharp price-driven surge of 2024. Although unit prices remain high, the pace of increase has slowed considerably, supporting a modest recovery in volume sales as consumers adjust to improved price stability. Visibility of dermatologicals is improving as products become more widely available through grocery retailers, enhancing consumer awareness and accessibility.

Dermatologicals in Singapore is recording rising value sales in 2025, driven mainly by a growing product variety and strong competition from both international and regional players. The category is expanding faster in 2025 than in the previous year, with dermatologicals seeing new brand entries and portfolio extensions from manufacturers active in adjacent health segments gain ground.

Value growth of dermatologicals in Kenya in 2025 was driven by environmental factors, a growing older population, and the rising incidence of common dermatological conditions. In addition, dermatologicals continues to be supported by rising consumer awareness thanks to the active efforts of both doctors and pharmacists.

Current sales of dermatological products in Ireland increased in 2025, reflecting a growing focus on skincare and a heightened awareness of skin health as an integral part of overall wellness. The prevalence of mild skin conditions, such as eczema and hair loss, continues to rise and is better understood, with local consumers often opting to self-medicate at home rather than consulting a medical professional due to privacy and convenience concerns.

Dermatologicals in Spain is projected to see further healthy growth in retail current value sales over 2025, largely in line with the 2024 performance, as inflationary pressure on prices stabilises. Topical germicidals/antiseptics is set to lead retail value sales at the end of the review period, with many consumers appreciating their benefits, such as wound care/protection, hygiene and the prevention of infections, as well as wide access in OTC terms in retailing. In a robust cross-category tre

In 2025, dermatologicals in Italy recorded relatively flat growth, marking the end of the upturn caused by the pandemic. Antiparasitics/lice (head and body) treatments, medicated shampoos, antifungals and antiseptics, were supported almost exclusively by price increases, whilst volume sales declined reflecting weaker consumer demand and overall maturity. By contrast, hair loss products and antipruritics continue to show signs of growth in both volume and value terms, supported by the rising inci

Dermatologicals in South Africa is projected to continue to see strong growth in retail current value sales over 2025, albeit slower than in previous years of the review period as inflationary pressure on prices sees some stabilisation, while remaining significant. Retail volume sales are also expected to grow across categories in dermatologicals over 2025, albeit more slowly in many cases, compared with 2024. The upward trajectory of retail volume and current value sales is supported by several

Dermatologicals in North Macedonia is set to register healthy growth in current value sales in 2025, while volume growth rates for the majority of categories are expected to be up on 2024. The use of these products is steadily increasing as the self-medication trend becomes more entrenched and the prevalence of different types of skin and hair problems in the country rises due to factors like population ageing, dietary and lifestyle habits, chronic stress and frequent exposure to environmental i

In 2025, value sales of dermatologicals in Hong Kong continue to grow alongside the increase in outdoor activities among local consumers. As more people embrace outdoor pursuits - whether it be hiking, running or enjoying parks - they are becoming more susceptible to skin allergies and irritations.

Retail value sales of dermatologicals are set to grow in current terms in Indonesia in 2025, supported by a greater consumer emphasis on skin health and hygiene in both preventive and curative contexts. The rise in dermatological conditions such as fungal infections, acne, and contact dermatitis is partly attributable to Indonesia’s tropical climate, increased pollution in urban areas, and frequent mask-wearing in crowded spaces.

Dermatologicals has seen steady growth in current value terms in 2025. Price increases, especially in less essential areas of dermatologicals, has driven value growth, although inflation has also artificially boosted sales. Access issues in dermatology and cost-of-living concerns have, however, led consumers to push less essential skin treatments down their list of priorities, which has dampened volume sales. Sales of dermatologicals have been hindered to an extent by the ongoing crisis in derma

Dermatologicals in Thailand continues to see steady growth in current value terms in 2025. This growth is being driven by a combination of factors including increasing health awareness, a growing focus on self-medication, convenience-driven OTC purchases, the impact of Thailand’s hot and humid climate, a rise in sensitive skin conditions (linked to pollution and overuse of some beauty and personal care products), as well as the country's status as a medical tourism hub. Nonetheless, the category

In Saudi Arabia, 2025 is seeing value sales rise for dermatologicals. The category continues to be influenced by the country’s harsh climate, high temperatures, desalinated water and other environmental factors which create conditions favourable for skin issues and complaints. The growing presence of dermocosmetics and skincare brands, coupled with ongoing promotional activities across various distribution channels, supports demand for dermatological products. At the same time, increased health

In 2025, the rate of growth in retail current value sales of dermatologicals in Uzbekistan slowed but remained in double-digits. One of the key factors driving this growth was the intensification of hot and dry weather across much of the country. Prolonged exposure to the heat not only aggravated existing skin conditions but also triggered a higher incidence of heat-related rashes, contact dermatitis, fungal infections, and photoallergic reactions, prompting increased demand for topical treatmen

Value sales of dermatologicals increased in Greece in 2025, primarily driven by retail price hikes among leading brands. In all categories, value growth outpaced volume growth, reflecting both price increases and the rising penetration of higher-priced, added-value SKUs. For example, within nappy (diaper) rash treatments, while Sudocrem remains the preferred choice among the elderly, growth in child-specific products is being fuelled by premium brands such as Frezyderm and Weleda.

Dermatologicals is expected to register muted current value growth in Portugal in 2025, but it is still expected to be positive value growth. Development of increasingly specific and advanced products sustain value sales. Social media also increasingly plays a role in terms of messaging and in particular in relation to dermatologicals that blur the lines with beauty care. Vaginal antifungals are expected to register the highest value growth, though from a low base. There is more awareness among

Dermatologicals is set to register a second consecutive year of double-digit growth in current value terms in 2025. The category has been positively affected by the sharp appreciation of Argentina’s official exchange rate in February 2024 which immediately impacted cross-border price dynamics. Small-scale smuggling fell notably in the first half of 2025, reducing the attractiveness of purchasing products in Argentina and redirecting demand back to local retailers.

Dermatologicals has seen positive growth in current value terms in 2025. Sales have benefited from increased awareness around dermatological issues and the products available to treat them and from the growing number of consumers with related conditions. Topical antifungals remains the leading category, with it seeing solid growth in 2025 in current value terms. These products are used to treat a range of conditions such as athlete’s foot, ringworm and fungal nail infections, with sales benefiti

In Malaysia, value sales of dermatologicals continue to grow in 2025. Demand remains steady across segments such as antifungals and antipruritics, supported by broad product availability and growing consumer confidence in self-purchasing. Improved awareness of treatment options is encouraging more consumers to manage skin conditions without visiting general practitioners.

Dermatologicals continues to post solid single-digit retail value growth in 2025. Demand is supported by strong sales of topical antifungals and other dermatologicals, with consumers increasingly turning to products for issues such as hair loss, dandruff, acne and dermatitis. Price increases are also contributing to retail value growth, although they are limiting volume growth in certain segments.